Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01422993|
Recruitment Status : Completed
First Posted : August 25, 2011
Last Update Posted : December 29, 2016
|Condition or disease||Intervention/treatment||Phase|
|Neuropathy Gastrointestinal Cancer||Other: 12 Week Exercise Program||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||4 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||A Pilot Study of a Strength and Balance Training Program for Persons With Oxaliplatin Induced Peripheral Neuropathy|
|Study Start Date :||July 2011|
|Actual Primary Completion Date :||April 2016|
|Actual Study Completion Date :||December 2016|
Experimental: Excercise and Questionnaire
12 week exercise program followed by questionnaire.
Other: 12 Week Exercise Program
Participants will be asked to take part in a one hour exercise program twice a week for 12 weeks. They will also be asked to answer questionnaires and participate in an evaluation of their strength, balance, and physical function every 4 weeks immediately following the exercise program. This evaluation will take an additional hour every 4 weeks.
- Number of Screened Patients Who Participate and Complete the Study [ Time Frame: 10 Months ]To evaluate feasibility, the percentage of patients screened to percentage enrolled in the study and the percentage enrolled to percentage that completes the study will be calculated. Patients who do not complete the study will be contacted to determine why they were unable to complete the study and the reasons will be recorded. How many sessions were attended will also be recorded.
- Number of Participants Who Experience Side Effects [ Time Frame: 10 Months ]To evaluate tolerability, at each session, data regarding any participant who was unable to complete the entire session will be recorded along with any side effects that participants report. Participants will also be asked to rate the level of exercise they perform at each session as either a) too easy b) just right c) too challenging.
- Number of Participants With Measured Improvement [ Time Frame: 10 Months ]Treatment-effect size will be evaluated by means of changes in muscle strength, balance, and neuropathy from the beginning to completion of the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01422993
|United States, Florida|
|H. Lee Moffitt Cancer Center and Research Institute|
|Tampa, Florida, United States, 33612|
|Principal Investigator:||Cindy Tofthagen, Ph.D., ARNP||University of South Florida|